The Canadian Government has awarded a $980,000 grant to Toronto-based medical device company Perimeter Medical Imaging to develop and test an innovative new breast cancer imaging tool.

The grant will support the next phase of product and clinical development and also streamline regulatory clearances for the company’s optical tissue imaging system (OTIS).

Discover B2B Marketing That Performs

Combine business intelligence and editorial excellence to reach engaged professionals across 36 leading media platforms.

Find out more

This will enable surgeons, radiologists and pathologists to review tissue microstructure during tumour removal surgery.

"Our government is proud to support an innovative company that is bringing new technology to the fight against cancer."

The intra-operative imaging tool is expected to decrease the requirement for follow-up surgeries, reducing hospital costs while offering better healthcare for patients.

Canadian MP for Don Valley West John Carmichael said: "Our government is proud to support an innovative company that is bringing new technology to the fight against cancer.

"Perimeter Medical Imaging is an example of an early-stage company that is poised for growth.

GlobalData Strategic Intelligence

US Tariffs are shifting - will you react or anticipate?

Don’t let policy changes catch you off guard. Stay proactive with real-time data and expert analysis.

By GlobalData

"We look forward to seeing Perimeter’s success in markets around the world while they create high-quality jobs right here in southern Ontario."

Perimeter Medical Imaging president Paul Weber said: "With FedDev Ontario’s support, we will triple in size with high-value jobs here in Toronto over the next year, and will accelerate market launch of our first product, taking leading edge Canadian innovation to international markets."

The system will provide clinicians with a high-resolution image of the entire surface of the removed tissue sample, enabling better decisions.

More than 25% of patients require a second surgery in breast cancer lumpectomy surgeries, because of cancer cells left behind.

The project is expected to create 18 new jobs in the greater Toronto area, leverage an additional $4m in private sector investment, $300,000 in government investments, and more $5m in private sector investments by 2016.

Perimeter plans to launch OTIS into the American market by 2016 and secure regulatory approval in Europe and Canada in 2017.

Medical Device Network Excellence Awards - The Benefits of Entering

Gain the recognition you deserve! The Medical Device Network Excellence Awards celebrate innovation, leadership, and impact. By entering, you showcase your achievements, elevate your industry profile, and position yourself among top leaders driving medical devices advancements. Don’t miss your chance to stand out—submit your entry today!

Nominate Now